On the other hand, HDAC inhibitors disrupt the balance between apoptosis and anti-apoptotic processes in cells, inducing the expression of pro-apoptotic genes, which then trigger tumor apoptosis through the mitochondrial (intrinsic pathway) or death receptor activation (extrinsic pathway) [78]. Here, HDAC9 is linked to neoplasm.